Does lorazepam (Ativan) increase restless‑leg syndrome symptoms?

Lorazepam (Ativan) Does Not Increase Restless Leg Syndrome Symptoms

Lorazepam does not worsen RLS symptoms, but it is not recommended as a treatment for RLS because benzodiazepines lack efficacy for the underlying sensorimotor disorder and carry significant risks including sedation, dependence, and withdrawal. The most recent 2025 American Academy of Sleep Medicine guidelines explicitly recommend against using benzodiazepines, including clonazepam (a related agent), for RLS treatment 1.

Key Evidence

Guideline Recommendations

The 2025 AASM clinical practice guideline specifically states: "In adults with RLS, the AASM suggests against the use of clonazepam (conditional recommendation, very low certainty of evidence)" 1. While this recommendation addresses clonazepam specifically, it reflects the broader position on benzodiazepines as a class for RLS management. Lorazepam (Ativan) is not mentioned as a treatment option in any contemporary RLS guidelines, indicating it has no established role in RLS therapy.

Why Benzodiazepines Are Not Recommended

A 2017 Cochrane systematic review found no randomized controlled trials meeting inclusion criteria to support benzodiazepine use for RLS 2. The American Academy of Sleep Medicine has stated that benzodiazepines should not be used as first-line treatment, though they could potentially serve as adjunctive therapy—but even this limited role is not supported by quality evidence.

FDA Drug Label Information

The Ativan (lorazepam) FDA label lists several adverse effects relevant to this question 3:

• Paradoxical reactions including "restlessness" and "agitation" are documented as rare adverse events
• The label specifically warns: "As with all benzodiazepines, paradoxical reactions such as stimulation, mania, irritability, restlessness, agitation, aggression, psychosis, hostility, rage, or hallucinations may occur in rare instances" 3

However, this "restlessness" refers to a paradoxical CNS stimulation effect, not the specific sensorimotor symptoms of RLS (urge to move legs with dysesthesias that worsen at rest and improve with movement).

Clinical Interpretation

Does Ativan Cause or Worsen RLS?

No clear evidence exists that lorazepam causes or exacerbates true RLS symptoms. The restlessness mentioned in the FDA label represents a different phenomenon—a paradoxical behavioral activation rather than the characteristic sensorimotor urge to move the legs that defines RLS.

Why Patients Might Receive Ativan for RLS (And Why This Is Problematic)

Some clinicians historically prescribed benzodiazepines like lorazepam for RLS based on the rationale that:

• They promote sleep initiation
• They may reduce anxiety about symptoms
• They have muscle relaxant properties

However, this approach is fundamentally flawed because:

1. Benzodiazepines do not address the underlying pathophysiology of RLS (iron deficiency, dopaminergic dysfunction)
2. They mask symptoms through sedation rather than treating the sensorimotor disorder
3. Long-term use carries substantial risks: dependence, withdrawal, cognitive impairment, falls (especially in elderly), and rebound symptoms 3
4. No quality evidence supports their efficacy for RLS-specific symptoms 2

Current Evidence-Based Treatment Approach

The 2025 AASM guidelines recommend the following hierarchy 1, 4:

First-Line Treatments (Strong Recommendations)

• Gabapentin (strong recommendation, moderate certainty)
• Pregabalin (strong recommendation, moderate certainty)
• IV ferric carboxymaltose in patients with appropriate iron parameters (strong recommendation, moderate certainty)

Conditional Recommendations

• Ferrous sulfate (oral iron)
• Extended-release oxycodone and other opioids (for refractory cases)
• IV low molecular weight iron dextran or ferumoxytol

Explicitly NOT Recommended

• Dopamine agonists (pramipexole, ropinirole, rotigotine) for standard use due to augmentation risk
• Benzodiazepines (clonazepam specifically mentioned)
• Cabergoline (strong recommendation against)

Clinical Pitfalls to Avoid

1. Do not confuse benzodiazepine-induced "restlessness" with RLS: The paradoxical agitation from lorazepam is a CNS stimulation effect, not the sensorimotor urge characteristic of RLS

2. Do not use benzodiazepines to treat insomnia in RLS patients: While they may help sleep initiation, they don't address the underlying leg discomfort and create dependency risk

3. Recognize drug-induced RLS triggers: Antihistamines (even second-generation like fexofenadine 5), antidepressants, antipsychotics, and PPIs (lansoprazole 6) can trigger or worsen RLS—but benzodiazepines are not established triggers

4. Check iron status first: Ferritin and transferrin saturation should be assessed before initiating any pharmacotherapy, as iron deficiency is a core pathophysiological mechanism 1, 4

Bottom Line

Lorazepam does not increase RLS symptoms based on available evidence. However, it should not be used to treat RLS because it lacks efficacy for the underlying disorder, does not address pathophysiology, and carries significant risks without proven benefit. If a patient with RLS is currently taking lorazepam, consider whether it was inappropriately prescribed for RLS-related insomnia and transition to evidence-based treatments (α2δ ligands like gabapentin/pregabalin or iron supplementation) 1, 4.